| P50 | author | Erich Gulbins | Q37611826 |
| | Ildikó Szabó | Q40971068 |
| | Luigi Leanza | Q61163903 |
| P2093 | author name string | K George Chandy | |
| | Mario Zoratti | |
| | Nicola Sassi | |
| | Brian Henry | |
| P2860 | cites work | Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes | Q21143901 |
| | Hematopoietic malignancies demonstrate loss-of-function mutations of BAX | Q24321995 |
| | Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes | Q24652512 |
| | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 |
| | Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum | Q28254691 |
| | Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels | Q28261952 |
| | Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases | Q28267180 |
| | Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation | Q28284440 |
| | International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels | Q28289179 |
| | A novel potassium channel in lymphocyte mitochondria | Q28301096 |
| | Methods in mammalian autophagy research | Q29547276 |
| | Production of large amounts of hydrogen peroxide by human tumor cells | Q29617080 |
| | BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis | Q29620466 |
| | Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis | Q33854131 |
| | Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators | Q34322193 |
| | In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells | Q34582817 |
| | ROS stress in cancer cells and therapeutic implications | Q35781703 |
| | bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis | Q36040551 |
| | Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers | Q36558200 |
| | Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques | Q36666549 |
| | Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution | Q37264027 |
| | Targeting ion channels in cancer: a novel frontier in antineoplastic therapy | Q37370358 |
| | The functional network of ion channels in T lymphocytes | Q37597609 |
| | Interaction of mitochondrial potassium channels with the permeability transition pore | Q37663104 |
| | Contribution of voltage-gated potassium channels to the regulation of apoptosis. | Q37681686 |
| | Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells | Q38291180 |
| | Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo | Q39630130 |
| | Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints. | Q39684234 |
| | Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. | Q39746194 |
| | An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtKCa3.1. | Q39758627 |
| | Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer | Q39807311 |
| | Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma | Q40166932 |
| | Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy | Q40321304 |
| | Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells | Q40356565 |
| | Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol. | Q40572288 |
| | Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count | Q40762411 |
| | A role for mitochondrial Bak in apoptotic response to anticancer drugs | Q40793451 |
| | Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels | Q40816569 |
| | Endogenous voltage-gated potassium channels in human embryonic kidney (HEK293) cells | Q41033148 |
| | Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669. | Q41035921 |
| | Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo | Q41480954 |
| | The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms | Q41578794 |
| | Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents | Q42435827 |
| | Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. | Q42790829 |
| | Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo | Q43288452 |
| | Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells | Q43902939 |
| | Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. | Q43903493 |
| | Voltage-gated potassium ion channels in colon cancer. | Q44094664 |
| | Activity of potassium channel-blockers in breast cancer. | Q44554023 |
| | Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. | Q45229108 |
| | A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma | Q46199288 |
| | Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. | Q47734211 |
| | Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas | Q47773428 |
| | Identification of a voltage-gated potassium channel in gerbil hippocampal mitochondria. | Q48156276 |
| | Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer | Q48373384 |
| | The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy | Q58176158 |
| | Superoxide generation by the respiratory chain of tumor mitochondria | Q69808847 |
| | A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma | Q74467049 |
| | Reduced Kv1.3 potassium channel expression in human prostate cancer | Q80423725 |
| P433 | issue | 7 | |
| P304 | page(s) | 577-593 | |
| P577 | publication date | 2012-04-11 | |
| P1433 | published in | EMBO Molecular Medicine | Q15817279 |
| P1476 | title | Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells | |
| P478 | volume | 4 | |